3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
37
Carcinoma, Non-Small-Cell Lung
24
Squamous Cell Carcinoma of Head and Neck
18
Melanoma
17
Colorectal Neoplasms
16
Urinary Bladder Neoplasms
11
Breast Neoplasms
11
Liver Neoplasms
10
Biliary Tract Neoplasms
10
Small Cell Lung Carcinoma
9
Prostatic Neoplasms
9
Lung Neoplasms
9
Diabetes Mellitus, Insulin-Dependent, 12
9
Carcinoma, Renal Cell
9
Neoplasms
8
Cholangiocarcinoma
7
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Head and Neck Neoplasms
6
Adenocarcinoma Of Esophagus
6
Stomach Neoplasms
5
Neoplasm Metastasis
5
Mesothelioma, Malignant
5
Fallopian Tube Neoplasms
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
3
Recurrence
3
Mesothelioma
3
Esophageal Squamous Cell Carcinoma
3
Endometrial Neoplasms
3
Interventions
Gemcitabine
4
Leucovorin
2
Fluorouracil
2
tremelimumab
1
pamrevlumab
1
irinotecan sucrosofate
1
folfirinox
1
durvalumab
1
Taxes
1
Radiosurgery
1
Oxaliplatin
1
Medical Marijuana
1
Irinotecan
1
Heavy Ion Radiotherapy
1
Chemoradiotherapy
1
Capecitabine
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pancreatic Cancer Non-resectable
×
tremelimumab
×
Clear all
NCT04156087
2024-09-19
MIMIPAC
University Hospital, Gasthuisberg
Phase 2
Completed
12 enrolled